Fox Corporation to Acquire Tubi

NEW YORK and LOS ANGELES, March 17, 2020 /PRNewswire/ — Fox Corporation (Nasdaq: FOXA, FOX) today announced that it has entered into a definitive agreement to acquire Tubi  for approximately $440 million in net cash consideration at closing with potential additional consideration in the form of deferred consideration and unvested options totaling approximately…Read More

Read More
Cortexyme Announces $125 Million Private Placement

FLG Partner’s client, Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat Alzheimer’s and other degenerative diseases, announced February 5, 2020 that it has entered into stock purchase agreements with a group of institutional investors and an entity affiliated with a member…Read More

Read More
RAPT Therapeutics Completes IPO

In December 2019, FLG client, RAPT Therapeutics announced earnings and results following the company’s initial public offering (IPO) which raised $33.8 million in net proceeds including the underwriters’ exercise of their over-allotment option to purchase additional shares at the IPO price. The Company’s stock commenced trading on the Nasdaq Global…Read More

Read More
Nitro Software Limited Completes IPO

December 11, 2019 – Nitro Software Limited (NTO) commenced trading on the Australian Securities Exchange (ASX) today, following a successful initial public offering raising total proceeds of $110.2 million at a price of $1.72 per share.  At the IPO listing price, Nitro has a market capitalization of $324.9 million and an…Read More

Read More
Oyster Point Pharma Completes Its IPO

December 5, 2019 – Oyster Point Pharma announced today the completion of its IPO. Company press release. FLG partner: Mark Murray.

Read More